References
- Min JE, Pearce LA, Homayra F, et al. Estimates of opioid use disorder prevalence from a regression-based multi-sample stratified capture-recapture analysis. Drug Alcohol Dependence. 2020 [2020 Dec 1];217:108337.
- Public Health Agency of Canada. Apparent opioid and stimulant toxicity deaths: surveillance of opioid- and stimulant-related harms in Canada. Ottawa, Ontario: Public Health Agency of Canada; 2021. https://publications.gc.ca/collections/collection_2021/aspc-phac/HP33-3-2021-eng-1.pdf.
- Crichton T, Schultz K, Lawrence K, et al. Assessment objectives for certification in family medicine. College of Family Physicians of Canada: Mississauga, Ontario. 2020. https://www.cfpc.ca/CFPC/media/Resources/Examinations/Assessment-Objectives-for-Certification-in-FM-full-document.pdf
- Mackey K, Veazie S, Anderson J, et al. Barriers and facilitators to the use of medications for opioid use disorder: a rapid review. J Gen Intern Med. 2020 2020 Dec 1;35(3):954–963. DOI:10.1007/s11606-020-06257-4
- Kunz K, Wiegand T. Addiction medicine: current status of certification, maintenance of certification, training, and practice.J Med Toxicol. 2016 [2016 Mar 1];12(1):76–78. DOI:10.1007/s13181-015-0524-6
- Derefinko KJ, Brown R, Danzo A, et al. Addiction medicine training fellowships in North America: a recent assessment of progress and needs. J Addict Med. 2020;14(4):e103–109. DOI:10.1097/ADM.0000000000000595
- Klimas J, Hamilton MA, Carney G, et al. Individualized prescribing portraits to reduce inappropriate initiation of opioid analgesics to opioid naïve patients in primary care: protocol for a randomized controlled trial. Contemp Clin Trials. 2021 [2021 Aug 1];107:106462.
- Narayan S, Rizzardo S, Hamilton M-A, et al. Development and pilot evaluation of an educational session to support sparing opioid prescriptions to opioid naïve patients in a Canadian primary care setting. Fam Pract. 2022;39(6):1024–1030. DOI:10.1093/fampra/cmac044
- Kiger ME, Varpio L. Thematic analysis of qualitative data: aMEE Guide No. 131.Med Teach. 2020 [2020 Aug 2];42(8):846–854. DOI:10.1080/0142159X.2020.1755030
- Damschroder LJ, Aron DC, Keith RE, et al. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009 2009 Aug 7;4(1):50. DOI:10.1186/1748-5908-4-50
- Kirane H, Drits E, Ahn S, et al. Addressing the opioid crisis: an assessment of clinicians’ training experience, practices, and attitudes within a large healthcare organization. J Opioid Manag. 2019;15(3):193–204. DOI:10.5055/jom.2019.0503
- Wakeman SE, Baggett MV, Pham-Kanter G, et al. Internal medicine residents’ training in substance use disorders: a survey of the quality of instruction and residents’ self-perceived preparedness to diagnose and treat addiction. Subst Abus. 2013 2013 Oct 1;34(4):363–370. DOI:10.1080/08897077.2013.797540
- DeFlavio JR, Rolin SA, Nordstrom BR, et al. Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians. Rural Remote Health. 2015;15:3019.
- Lanham HJ, Papac J, Olmos DI, et al. Survey of barriers and facilitators to prescribing buprenorphine and clinician perceptions on the drug addiction treatment act of 2000 waiver. JAMA Netw Open. 2022;5(5):e2212419. DOI:10.1001/jamanetworkopen.2022.12419
- Canadian Institute for Health Information. Opioid-related Harms in Canada. Ottawa ON: CIHI; 2018.
- Haffajee RL, Bohnert ASB, Lagisetty PA. Policy pathways to address provider workforce barriers to buprenorphine treatment.Am J Preventive Med. 2018 [2018 Jun 1];54(6, Supplement 3):S230–242. DOI:10.1016/j.amepre.2017.12.022